Yes. Several companies currently offer commercial 3D bioprinting platforms suitable for tissue-engineering and biofabrication research. The main options differ substantially in printing method, resolution, throughput, and whether they target research models versus eventual clinical translation.
Company
Representative platform
Technology
Particularly suited for
CELLINK
BIO X / BIO X6 / LUMEN X / BIONOVA X
Extrusion, DLP/light-based
Broad tissue engineering, cell-laden scaffolds, multi-material constructs, 3D cell culture
Complex tissue models, skin, bone, regenerative medicine
Poietis Biosystems
NGB-R
Laser-assisted + bioextrusion
High-resolution cellular patterning, tissue models, regenerative medicine
Inventia Life Science
RASTRUM
Automated volumetric/bioprinting approach
Reproducible 3D cell and tissue models, disease modeling, drug screening
Aspect Biosystems
Lab-on-a-Printer / tissue-therapeutic platform
Microfluidic bioprinting
Complex multicellular tissues and regenerative medicine
3D Systems / Advanced Solutions Life Sciences
BioAssemblyBot family
Robotic extrusion/bioassembly
Large, complex constructs and research biofabrication
ROKIT Healthcare
Dr. INVIVO
Extrusion bioprinting
Tissue regeneration and regenerative-medicine research
The strongest research-oriented choices
CELLINK is probably the most broadly applicable starting point. Its BIO X is explicitly designed for cell biologists, tissue engineers and biomedical researchers, while the BIO X6 provides six printheads for multi-material constructs. CELLINK also offers a large ecosystem of bioinks and biomaterials.
REGENHU is especially interesting if your work involves complex, customized tissue constructs. Its R-GEN systems can combine different dispensing/printing technologies and add electrowriting for micro/nanofibers. The company specifically markets the systems for tissue engineering, regenerative medicine and drug discovery.
Poietis is the standout if cell-level spatial precision is important. Its NGB-R combines laser-assisted bioprinting with bioextrusion; the laser system deposits picoliter-scale droplets without nozzle contact and is intended for research applications including tissue and disease models.
Inventia takes a somewhat different approach, concentrating on highly reproducible 3D cell models rather than conventional large scaffold printing. Its RASTRUM platform is aimed at creating tissue/disease microenvironments and scalable models for therapeutic research; for example, Inventia demonstrates 3D liver models using primary human hepatocytes.
Aspect Biosystems is worth distinguishing from conventional equipment vendors: its technology is heavily oriented toward engineering functional, implantable tissues, integrating proprietary bioprinting, computational design, cells and biomaterials. It is therefore particularly relevant if your objective includes eventual regenerative-medicine translation rather than simply purchasing a benchtop printer.
High-throughput 3D tissue/cell models:Inventia RASTRUM
Long-term regenerative medicine / tissue therapeutics:Aspect Biosystems
One important distinction: not every "3D bioprinter" is designed to make implantable tissue. Some are primarily research instruments for cell culture, disease models and drug screening, while others are being developed around clinical/regenerative-medicine workflows. For example, Poietis explicitly separates its NGB-R research system from its GMP-oriented NGB-C platform.
If you're evaluating equipment for a tissue-engineering lab, I can also make a side-by-side comparison of 10–15 commercially available bioprinters, including approximate price, print technology, resolution, number of printheads, sterile enclosure, bioink compatibility, build volume, and best tissue applications.
A variety of specialized companies offer 3D bioprinting technology, bioinks, and hardware tailored for tissue engineering, regenerative medicine, and preclinical research.
Leading providers of 3D bioprinting systems for academic and industrial research include:
CELLINK (BICO Group) : Widely recognized for systems like the CELLINK BIO X series, they provide universally adopted bioprinters alongside a broad catalog of customizable bioinks designed for diverse cell types and tissue structures.
regenHU : Based in Switzerland, they manufacture versatile, high-precision industrial and research bioprinting systems (such as the 3D Discovery platform) engineered for multi-material deposition in complex tissue models.
3D-Bioplotter (EnvisionTEC / ETEC, part of Desktop Metal) : An established high-precision pneumatic extrusion system used extensively globally for processing complex biomaterials, polymers, hydrogels, and ceramics in tissue scaffolding.
Allevi (acquired by 3D Systems) : Known for accessible, user-friendly desktop bioprinters designed to fit inside standard laboratory incubators, simplifying live-cell printing workflows.
REGEMAT 3D : Specializes in customizable, modular open-source and clinical-research bioprinters that allow researchers to adapt printing heads and parameters to specific tissue engineering projects.
Advanced Solutions Life Sciences : Creators of the BioAssemblyBot , a robotic 3D bioprinting platform driven by proprietary software designed for high-precision tissue structure fabrication.
Aspect Biosystems : Focuses on proprietary microfluidic bioprinting platforms to engineer high-resolution living tissues for regenerative medicine and therapeutic discovery.
If you are looking for a specific capability, let me know:
Are you focusing on extrusion, stereolithography (SLA/DLP), or droplet-based bioprinting?
Do you need assistance with bioink selection or a particular tissue type (e.g., bone, skin, vascular networks)?
